17.05 -1.09 (-6.09%)
REGN
Stock Details
Last Trade:17.05 Change:-1.09 (-6.09%) Prev Close:18.14 Open: 17.90 Days Range:16.85 – 17.90 52 Week Range: 11.81 - 25.00 Volume:578222 P/E: N/AEPS:-1.12
View AllRecent Alerts 07/04/09
Recent Alert on 06/11/09 at 8:34am
Sanofi-aventis (SNY) and Regeneron (REGN) Announce Results from Phase 2 Study with Aflibercept (VEGF Trap) in Advanced Ovarian Cancer Patients
Sanofi-aventis (SNY) and Regeneron (REGN) Announce Results from Phase 2 Study with Aflibercept (VEGF Trap) in Advanced Ovarian Cancer Patients
Sanofi-aventis (NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that advanced ovarian cancer patients with recurrent symptomatic malignant ascites (SMA) receiving aflibercept (VEGF Trap) in a randomized, placebo-controlled... Read More
Recent Alert on 05/05/09 at 7:36am
ThinkEquity Initiates Coverage on Regeneron (REGN) with an Accumulate
ThinkEquity Initiates Coverage on Regeneron (REGN) with an Accumulate
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 06/19/09 at 7:14am
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Blog Posts on 03/30/09 at 12:15pm
Analyst upgrades, downgrades and initiations: VOD, CBS, BCS, MS, ICE, AU ...
Analyst upgrades, downgrades and initiations: VOD, CBS, BCS, MS, ICE, AU ...